Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Scott A. Weisenberg"'
Autor:
Scott A. Weisenberg, Audrey N. Schuetz, Elizabeth A. Alexander, Brain Eiss, Maryam Behta, Lisa Saiman, Davise H. Larone, Stephen G. Jenkins, Kyu Y. Rhee
Publikováno v:
PLoS ONE, Vol 7, Iss 10 (2012)
Externí odkaz:
https://doaj.org/article/f351daa85fda4ffd99d629f56601a855
Autor:
Ioannis M Zacharioudakis, Fainareti N Zervou, Prithiv J Prasad, Yongzhao Shao, Atreyee Basu, Kenneth Inglima, Scott A Weisenberg, Maria E Aguero-Rosenfeld
Publikováno v:
PLoS ONE, Vol 15, Iss 11, p e0242399 (2020)
The Infectious Diseases Society of America has identified the use of SARS-CoV-2 genomic load for prognostication purposes as a key research question. We designed a retrospective cohort study that included adult patients with COVID-19 pneumonia who ha
Externí odkaz:
https://doaj.org/article/04698c6ff4ec47ebb0b036a93566c566
Autor:
Deborah Korenstein, Laura D. Scherer, Andrew Foy, Lisa Pineles, Alison D. Lydecker, Jill Owczarzak, Larry Magder, Jessica P. Brown, Christopher D. Pfeiffer, Christopher Terndrup, Luci Leykum, Deborah Stevens, David A. Feldstein, Scott A. Weisenberg, Jonathan D. Baghdadi, Daniel J. Morgan
Publikováno v:
Am J Med
BACKGROUND: Variation in clinicians’ diagnostic test utilization is incompletely explained by demographics and likely relates to cognitive characteristics. We explored clinician factors associated with diagnostic test utilization METHODS: Self-admi
Autor:
Jill Owczarzak, Daniel J. Morgan, Max Masnick, Deborah Stevens, Lisa Pineles, Laura D. Scherer, Andrew Foy, David A Feldstein, Larry Magder, Chris Pfeiffer, Luci K. Leykum, Deborah Korenstein, Jessica P. Brown, Christina Koch, Chris Terndrup, Scott A. Weisenberg
Publikováno v:
JAMA Network Open
Key Points Question How do clinicians conceptualize the benefits of treatments for common diseases? Findings In this survey study of 542 clinicians, most respondents significantly overestimated the benefits of common therapies. Clinicians who concept
Autor:
Maria E Aguero-Rosenfeld, Scott A. Weisenberg, Fainareti N. Zervou, Prithiv J. Prasad, Ioannis M. Zacharioudakis, Atreyee Basu, Yongzhao Shao, Kenneth Inglima
Publikováno v:
Open Forum Infectious Diseases
Background The Infectious Diseases Society of America has identified the potential use of SARS-CoV-2 genomic load for prognostication purposes as a key research question. Methods We designed a retrospective cohort study that included adult patients w
Autor:
Prithiv J. Prasad, Ioannis M. Zacharioudakis, Fainareti N. Zervou, Yongzhao Shao, Maria E Aguero-Rosenfeld, Kenneth Inglima, Atreyee Basu, Scott A. Weisenberg
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 11, p e0242399 (2020)
PLoS ONE, Vol 15, Iss 11, p e0242399 (2020)
The Infectious Diseases Society of America has identified the use of SARS-CoV-2 genomic load for prognostication purposes as a key research question. We designed a retrospective cohort study that included adult patients with COVID-19 pneumonia who ha
Autor:
Prithiv J. Prasad, Ioannis M. Zacharioudakis, Kenneth Inglima, Fainareti N. Zervou, Atreyee Basu, Maria E Aguero-Rosenfeld, Scott A. Weisenberg
RationaleThe Infectious Diseases Society of America has identified the use of SARS-CoV-2 genomic load for prognostication purposes as a key research question.ObjectivesWe explored the SARS-CoV-2 genomic load as a risk factor for adverse patient outco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c0d2fa784ded50eeb729b7f26bb5ac3
https://doi.org/10.1101/2020.07.02.20145151
https://doi.org/10.1101/2020.07.02.20145151
Autor:
Atreyee Basu, Scott A. Weisenberg, Kenneth Inglima, Maria E Aguero-Rosenfeld, Prithiv J. Prasad, Ioannis M. Zacharioudakis, Fainareti N. Zervou
Publikováno v:
Open Forum Infectious Diseases
Background SARS-CoV-2, the cause of COVID-19 pneumonia, is associated with heterogenous presentations ranging from asymptomatic infection to severe respiratory failure. We explored the association of SARS-CoV-2 genomic load as a risk factor for adver
Autor:
Theodoros Kelesidis, Heather Young, Edward Septimus, Marin L. Schweizer, Nikolay P. Braykov, Daniel Z. Uslan, Eli N. Perencevich, Ramanan Laxminarayan, Daniel J. Morgan, Birgir Johannsson, Arjun Srinivasan, Scott A. Weisenberg, Joseph B. Cantey
Publikováno v:
The Lancet. Infectious diseases, vol 14, iss 12
Summary Background Modification of empirical antimicrobials when warranted by culture results or clinical signs is recommended to control antimicrobial overuse and resistance. We aimed to assess the frequency with which patients were started on empir
A 63-year-old man developed scrotal swelling that became bilateral over 2 months. His symptoms persisted after treatment for epididymitis, and he developed a scrotal fistula with drainage. Mycobacterium tuberculosis grew from the urine and fistula. H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c3500470048f3d84d63100c3a9dc9ec
https://europepmc.org/articles/PMC5695325/
https://europepmc.org/articles/PMC5695325/